Experienced in Plasmacytoma

Dr. Fen Wang

Radiation Oncology
Kansas University Physicians Inc
4000 Cambridge St, 
Kansas City, KS 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Experienced in Plasmacytoma
Kansas University Physicians Inc
4000 Cambridge St, 
Kansas City, KS 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Fen Wang is a Radiation Oncologist in Kansas City, Kansas. Dr. Wang is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Meningioma, Lung Cancer, Pleuropulmonary Blastoma, and Posterior Fossa Tumor. Dr. Wang is currently accepting new patients.

His clinical research consists of co-authoring 2 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Radiation Oncology
Licenses
Radiology in KS
Hospital Affiliations
University Of Kansas Health System - St Francis Campus
University Of Kansas Hospital
Languages Spoken
English
German
Mandarin
Zhuang
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Home State Health
  • EPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Sunflower Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

KANSAS UNIVERSITY PHYSICIANS INC
4000 Cambridge St, Kansas City, KS 66160
Other Locations
KANSAS UNIVERSITY PHYSICIANS INC
3901 Rainbow Blvd, Suite 5300, Kansas City, KS 66160

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
Enrollment Status: Recruiting
Publish Date: September 08, 2025
Intervention Type: Other, Procedure, Radiation
Study Phase: Phase 3
Phase I Trial of Radiotherapy Combined With Durvalumab Alone Plus Either Monalizumab or Oleclumab in PD-L1 High Locally Advanced Non-Small Cell Lung Cancer (NSCLC) (ARCHON-1)
Phase I Trial of Radiotherapy Combined With Durvalumab Alone Plus Either Monalizumab or Oleclumab in PD-L1 High Locally Advanced Non-Small Cell Lung Cancer (NSCLC) (ARCHON-1)
Enrollment Status: Completed
Publish Date: September 23, 2025
Intervention Type: Biological, Procedure, Radiation
Study Drug: Durvalumab
Study Phase: Phase 1
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Enrollment Status: Active_not_recruiting
Publish Date: September 02, 2025
Intervention Type: Other, Drug, Radiation, Procedure
Study Drugs: Atezolizumab, Carboplatin, Cisplatin, Etoposide
Study Phase: Phase 3
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Enrollment Status: Active_not_recruiting
Publish Date: March 11, 2025
Intervention Type: Radiation, Drug
Study Drugs: Docetaxel, Gemcitabine, Pemetrexed Disodium, Erlotinib Hydrochloride, Pembrolizumab
Study Phase: Phase 2
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 17, 2024
Intervention Type: Radiation
Study Phase: Phase 2/Phase 3
View 4 Less Clinical Trials

2 Total Publications

Fgf9 from dermal γδ T cells induces hair follicle neogenesis after wounding.
Fgf9 from dermal γδ T cells induces hair follicle neogenesis after wounding.
Journal: Nature medicine
Published: January 01, 2013
Similar Doctors
Experienced in Plasmacytoma
Dr. Daniel Keleti
Radiation Oncology
Experienced in Plasmacytoma
Dr. Daniel Keleti
Radiation Oncology

Kansas University Physicians Inc

4000 Cambridge St, Suite G600, 
Kansas City, KS 
 (0.1 miles away)
913-588-1227
Languages Spoken:
English, Slovak
See accepted insurances
Accepting New Patients

Daniel Keleti is a Radiation Oncologist in Kansas City, Kansas. Dr. Keleti is rated as an Advanced provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Angiosarcoma. Dr. Keleti is currently accepting new patients.

Experienced in Plasmacytoma
Dr. Melisa G. Boersma
Radiation Oncology
Experienced in Plasmacytoma
Dr. Melisa G. Boersma
Radiation Oncology

University Of Kansas Hospital Authority

3901 Rainbow Blvd, 
Kansas City, KS 
 (0.2 miles away)
913-588-7743
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Melisa Boersma is a Radiation Oncologist in Kansas City, Kansas. Dr. Boersma is rated as an Advanced provider by MediFind in the treatment of Plasmacytoma. Her top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Angiosarcoma, and Liposarcoma. Dr. Boersma is currently accepting new patients.

Experienced in Plasmacytoma
Dr. Kelly L. Rhodes-Stark
Radiation Oncology
Experienced in Plasmacytoma
Dr. Kelly L. Rhodes-Stark
Radiation Oncology

Kansas University Physicians Inc

20333 W 151st St, Olathe Medical Center, 
Olathe, KS 
 (18.2 miles away)
913-588-1227
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kelly Rhodes-Stark is a Radiation Oncologist in Olathe, Kansas. Dr. Rhodes-Stark is rated as a Distinguished provider by MediFind in the treatment of Plasmacytoma. Her top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Familial Prostate Cancer, and Small Cell Lung Cancer (SCLC). Dr. Rhodes-Stark is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wang's expertise for a condition
ConditionClose
    View All 23 Distinguished Conditions
    View All 21 Advanced Conditions
    View All 38 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile